Capital International, Inc. Karuna Therapeutics, Inc. Transaction History

Capital International, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$161.01 - $317.85 $1.24 Million - $2.44 Million	7,684 Added 129.19%	13,632 $4.31 Million
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $186,724 - $247,302	-1,134 Reduced 16.01%	5,948 $1.01 Million
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $1.25 Million - $1.7 Million	7,082 New	7,082 $1.54 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $19.3 Million - $24 Million	-190,923 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $1.71 Million - $2.17 Million	-15,941 Reduced 7.71%	190,923 $21.8 Million
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $2.1 Million - $2.93 Million	-22,003 Reduced 9.61%	206,864 $24.9 Million
Q4 2020 Feb 16, 2021	SELL	$75.23 - $109.23 $209,816 - $304,642	-2,789 Reduced 1.2%	228,867 $23.3 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $268,320 - $506,112	4,318 Added 1.9%	231,656 $25.8 Million
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $13.7 Million - $26.4 Million	227,338 New	227,338 $16.4 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.